ADAM17: A new therapeutic target for triple negative breast cancer?

被引：0
|
作者：
McGowan, P. [1 ,2 ]
Mullooly, M. [1 ,2 ]
Sukor, S. [1 ,2 ]
O'Donovan, N. [3 ]
Duffy, M. J. [1 ,2 ]
机构：
[1] Univ Coll Dublin, Sch Med, Dublin 2, Ireland
[2] Univ Coll Dublin, Med Sci Conway Inst, Dublin 2, Ireland
[3] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)71834-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [21] WNT PATHWAY AS THERAPEUTIC TARGET OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Huelsewig, C.
    Goette, M.
    Ruckert, C.
    Buchweitz, O.
    Kiesel, L.
    Pusztai, L.
    Liedtke, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 39 - 39
  • [22] Evaluation of GABRP as a novel therapeutic target in triple negative breast cancer
    Wali, Vikram B.
    Patwardhan, Gauri A.
    Hatzis, Christos
    Pusztai, Lajos
    CANCER RESEARCH, 2017, 77
  • [23] Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
    Moss, Marcia L.
    Minond, Dmitry
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [24] SP17 as new immunotherapy target and biomarker for triple-negative breast cancer
    Chiriva-Internati, Maurizio
    Mirandola, Leonardo
    Cohos, Everardo
    Dahlbeck, Scott
    Nguyen, Diane
    Figueroa, Jose
    Rahman, Rakhshanda Layeequr
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [25] Dual Targeting of ADAM10 and ADAM17 as a Novel Therapy for Breast Cancer
    Mullooly, M.
    O'Brien, N.
    Finn, R. S.
    Slamon, D. J.
    Crown, J.
    McGowan, P. M.
    Duffy, M. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 171 - 171
  • [26] cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?
    Gaule, Patricia B.
    Crown, John
    O'Donovan, Norma
    Duffy, Michael J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (09) : 999 - 1009
  • [27] The metalloprotease ADAM17 in inflammation and cancer
    Duesterhoeft, Stefan
    Lokau, Juliane
    Garbers, Christoph
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (06)
  • [28] Therapeutic Advances and New Directions for Triple Negative Breast Cancer
    Andreopoulou, Eleni
    Kelly, Catherine M.
    McDaid, Hayley M.
    BREAST CARE, 2017, 12 (01) : 21 - 28
  • [29] ADAM8 drives aggressive phenotype of triple-negative inflammatory breast cancer & constitutes a novel therapeutic target
    Romagnoli, Mathilde
    Pianetti, Stefania
    Das, Sonia G.
    Loussouarn, Delphine
    Gourmelon, Carole
    Campone, Mario
    Barille-Nion, Sophie
    Nguyen, Giang T.
    Srinivasan, Srimathi
    Sonenshein, Gail E.
    Mineva, Nora D.
    CANCER RESEARCH, 2017, 77
  • [30] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    ONCOLOGY-NEW YORK, 2017, 31 : 13 - 20
12345